198 related articles for article (PubMed ID: 32581289)
1. Respiratory outcomes of metformin use in patients with type 2 diabetes and chronic obstructive pulmonary disease.
Yen FS; Wei JC; Yang YC; Hsu CC; Hwu CM
Sci Rep; 2020 Jun; 10(1):10298. PubMed ID: 32581289
[TBL] [Abstract][Full Text] [Related]
2. Metformin use and the risk of bacterial pneumonia in patients with type 2 diabetes.
Yen FS; Wei JC; Shih YH; Hsu CC; Hwu CM
Sci Rep; 2022 Feb; 12(1):3270. PubMed ID: 35228620
[TBL] [Abstract][Full Text] [Related]
3. Effects of metformin use on total mortality in patients with type 2 diabetes and chronic obstructive pulmonary disease: A matched-subject design.
Yen FS; Chen W; Wei JC; Hsu CC; Hwu CM
PLoS One; 2018; 13(10):e0204859. PubMed ID: 30286138
[TBL] [Abstract][Full Text] [Related]
4. Metformin and the Development of Asthma in Patients with Type 2 Diabetes.
Yen FS; Hsu CC; Shih YH; Pan WL; Wei JC; Hwu CM
Int J Environ Res Public Health; 2022 Jul; 19(13):. PubMed ID: 35805869
[TBL] [Abstract][Full Text] [Related]
5. Use of antidiabetic medications and risk of chronic obstructive pulmonary disease exacerbation requiring hospitalization: a disease risk score-matched nested case-control study.
Wang MT; Lai JH; Huang YL; Kuo FC; Wang YH; Tsai CL; Tu MY
Respir Res; 2020 Dec; 21(1):319. PubMed ID: 33267895
[TBL] [Abstract][Full Text] [Related]
6. Safety of metformin in patients with chronic obstructive pulmonary disease and type 2 diabetes mellitus.
Hitchings AW; Archer JR; Srivastava SA; Baker EH
COPD; 2015 Apr; 12(2):126-31. PubMed ID: 25938184
[TBL] [Abstract][Full Text] [Related]
7. Pioglitazone and Risk of Chronic Obstructive Pulmonary Disease in Patients with Type 2 Diabetes Mellitus: A Retrospective Cohort Study.
Tseng CH
Int J Chron Obstruct Pulmon Dis; 2022; 17():285-295. PubMed ID: 35177899
[TBL] [Abstract][Full Text] [Related]
8. Metformin and the Risk of Chronic Urticaria in Patients with Type 2 Diabetes.
Yen FS; Hsu CC; Hu KC; Hung YT; Hsu CY; Wei JC; Hwu CM
Int J Environ Res Public Health; 2022 Sep; 19(17):. PubMed ID: 36078769
[TBL] [Abstract][Full Text] [Related]
9. Metformin and risk of chronic obstructive pulmonary disease in diabetes patients.
Tseng CH
Diabetes Metab; 2019 Apr; 45(2):184-190. PubMed ID: 29804817
[TBL] [Abstract][Full Text] [Related]
10. Does chronic obstructive pulmonary disease with or without type 2 diabetes mellitus influence the risk of lung cancer? Result from a population-based cohort study.
Shen TC; Chung WS; Lin CL; Wei CC; Chen CH; Chen HJ; Tu CY; Hsia TC; Shih CM; Hsu WH; Chung CJ
PLoS One; 2014; 9(5):e98290. PubMed ID: 24854189
[TBL] [Abstract][Full Text] [Related]
11. Sulfonylurea Use in Patients with Type 2 Diabetes and COPD: A Nationwide Population-Based Cohort Study.
Yen FS; Wei JC; Yu TS; Hsu CY; Hsu CC; Hwu CM
Int J Environ Res Public Health; 2022 Nov; 19(22):. PubMed ID: 36429732
[TBL] [Abstract][Full Text] [Related]
12. Metformin Use Is Associated With a Lower Risk of Hospitalization for Heart Failure in Patients With Type 2 Diabetes Mellitus: a Retrospective Cohort Analysis.
Tseng CH
J Am Heart Assoc; 2019 Nov; 8(21):e011640. PubMed ID: 31630591
[TBL] [Abstract][Full Text] [Related]
13. Effects of metformin exposure on neurodegenerative diseases in elderly patients with type 2 diabetes mellitus.
Kuan YC; Huang KW; Lin CL; Hu CJ; Kao CH
Prog Neuropsychopharmacol Biol Psychiatry; 2017 Oct; 79(Pt B):77-83. PubMed ID: 28583443
[TBL] [Abstract][Full Text] [Related]
14. Metformin Is Associated with a Lower Incidence of Benign Brain Tumors: A Retrospective Cohort Study in Patients with Type 2 Diabetes Mellitus.
Tseng CH
Biomolecules; 2021 Sep; 11(10):. PubMed ID: 34680039
[No Abstract] [Full Text] [Related]
15. Metformin use and mortality in patients with advanced chronic kidney disease: national, retrospective, observational, cohort study.
Hung SC; Chang YK; Liu JS; Kuo KL; Chen YH; Hsu CC; Tarng DC
Lancet Diabetes Endocrinol; 2015 Aug; 3(8):605-14. PubMed ID: 26094107
[TBL] [Abstract][Full Text] [Related]
16. Diabetes risks and outcomes in chronic obstructive pulmonary disease patients: Two nationwide population-based retrospective cohort studies.
Lin CS; Liu CC; Yeh CC; Chang YC; Chung CL; Lane HL; Shih CC; Chen TL; Liao CC
PLoS One; 2017; 12(8):e0181815. PubMed ID: 28813433
[TBL] [Abstract][Full Text] [Related]
17. Metformin use and health care utilization in patients with coexisting chronic obstructive pulmonary disease and diabetes mellitus.
Bishwakarma R; Zhang W; Lin YL; Kuo YF; Cardenas VJ; Sharma G
Int J Chron Obstruct Pulmon Dis; 2018; 13():793-800. PubMed ID: 29551895
[TBL] [Abstract][Full Text] [Related]
18. Cardiovascular outcomes of metformin use in patients with type 2 diabetes and chronic obstructive pulmonary disease.
Yen FS; Wei JC; Chiu LT; Hsu CC; Hwu CM
Front Pharmacol; 2022; 13():919881. PubMed ID: 36071848
[No Abstract] [Full Text] [Related]
19. Outcomes associated with invasive and noninvasive ventilation among patients hospitalized with exacerbations of chronic obstructive pulmonary disease.
Lindenauer PK; Stefan MS; Shieh MS; Pekow PS; Rothberg MB; Hill NS
JAMA Intern Med; 2014 Dec; 174(12):1982-93. PubMed ID: 25347545
[TBL] [Abstract][Full Text] [Related]
20. Metformin and lung cancer risk in patients with type 2 diabetes mellitus.
Tseng CH
Oncotarget; 2017 Jun; 8(25):41132-41142. PubMed ID: 28456789
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
